Another 205,000 American workers filed for unemployment benefits last week, matching the prior week’s jobless claims number and roughly in line with pre-pandemic levels, suggesting that the recent rise in COVID-19 infections was not driving a fresh wave of layoffs.
As if the global economic condition were not severe enough after months of devastating impacts wrought by the COVID-19 pandemic, investors are warning that the possible collapse of a major Chinese real estate development company named Evergrande could trigger a liquidity crisis similar to the one that occurred in late 2008, leading to a multi-year global recession.
Later this week, the FDA plans to approve, as the first outpatient COVID drugs, therapeutics that are extremely dangerous and unproven, even as the agency goes to war against cheap, safe, and proven drugs with a track record of no serious adverse events.
Newsweek review of financial filings in Congress has found that lawmakers who are driving legislation to protect Uyghurs in China are also invested—either directly in the form of stocks, or indirectly via mutual funds—in major companies tied to the oppression in Xinjiang.
Surging inflation will cost millions of Americans more than $3,000 in additional expenses this year, according to a Penn Wharton University of Pennsylvania Budget Model (PWBM) analysis published on Wednesday.
Mariana Mazzucato, a professor at University College London, is listed as a contributor on the World Economic Forum's website, writing multiple pieces on behalf of the globalist (here, here) think tank.
